Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs051180015Phase 2Completed
Phase 2, randomised trial in thoracic cancer comparing Mannitol arm with Furosemide arm (2 arms). Primary endpoint: Primary: Grade >=1 renal dysfunction during first cycle. Started May 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs051180015.